Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

"Boston Scientific: evolving the cardiac rhythm management space" was originally created and published by Medical Device ...

(Reuters) -Boston Scientific ... strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events. Shares of the device maker fell about ...

Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a ...

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

Boston Scientific noted that the technologies are compatible exclusively with its existing cardiac mapping technology and the company's latest offering, the OPAL HDx Mapping System. The company ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...